APA (7th ed.) Citation

4th, B. A., EB, T., PN, N., D, G., H, M., AR, M., . . . A, S. (2026). Cardiovascular Risk Assessment Tools are Insufficient for Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease. The American journal of gastroenterology, 121(3), 710. https://doi.org/10.14309/ajg.0000000000003595

Chicago Style (17th ed.) Citation

4th, Barritt AS, et al. "Cardiovascular Risk Assessment Tools Are Insufficient for Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease." The American Journal of Gastroenterology 121, no. 3 (2026): 710. https://doi.org/10.14309/ajg.0000000000003595.

MLA (9th ed.) Citation

4th, Barritt AS, et al. "Cardiovascular Risk Assessment Tools Are Insufficient for Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease." The American Journal of Gastroenterology, vol. 121, no. 3, 2026, p. 710, https://doi.org/10.14309/ajg.0000000000003595.